IDONTRAX KRAS G12C enables reliable and differentiated detection of the KRAS G12C mutation, as well as identification of the wild-type allele, thanks to an optimised mix of primers and fluorescent probes, specifically designed for digital PCR (dPCR) analysis.
The test targets the G12C mutation in exon 2, a key alteration in oncology, whose accurate detection is essential for therapeutic guidance and patient follow-up.
Based on ICE* technology developed by ID SOLUTIONS, IDONTRAX KRAS G12C guarantees high sensitivity and excellent reproducibility, even on demanding clinical matrices such as plasma (cfDNA) or FFPE tissues (gDNA).
The reagents are supplied in pre-mixed tubes, with ready-to-use primers and probes, to simplify preparation, reduce handling and ensure optimal standardisation of results in routine laboratory practice.
*Not included in the kit.
